Physician profile
Minh Ho
NPI 1841281813
$8,030.74
in general payments reported to CMS, 2019-2025
15 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $17.20 · 2021: $1,329 · 2022: $942 · 2023: $2,984 · 2024: $1,017 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,473 · Travel and Lodging: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,473.14 |
| Travel and Lodging | $1,144.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,113.40 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,745.98 | 2019-2025 | Rhopressa, Rocklatan, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $1,401.42 | 2023-2025 | Miebo, Infuse, Xiidra |
| Oyster Point Pharma, INC. | $573.26 | 2022-2025 | Tyrvaya |
| Glaukos Corporation | $458.85 | 2023-2025 | Kxl System (Not Refurbished), Kxl1b-Ce-Marked Kxlsystem, Photrexa Viscous and Photrexa |
| Tarsus Pharmaceuticals, INC. | $358.94 | 2024-2025 | Xdemvy |
| Abbvie INC. | $352.38 | 2022-2023 | |
| Coopervision INC. | $307.55 | 2023-2025 | Misight Contact Lens, Myday Contact Lens |
| Lumenis Be INC | $252.05 | 2023 | Optilight |
| Biotissue Holdings INC. | $143.23 | 2023 | |
| Topcon Healthcare, INC. | $125.01 | 2024 | |
| Sun Pharmaceutical Industries INC. | $125.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $40.67 | 2022 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Visioneering Technologies, INC. | $15.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minh Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.